Thirona has extended its partnership with Pulmonx to develop and commercialize tools that diagnose and treat emphysema patients.
Pulmonx's StraX artificial intelligence (AI) and cloud-based quantitative CT analysis service StratX supports Zephyr endobronchial valve patient selection and treatment targeting by providing information on emphysema destruction, fissure completeness, and lobar volumes.
Meanwhile, Thirona's LungQ AI engine performs automated analytics of clinical data from lung CT scans. The AI-based software enables precise identification and quantification of anatomical structures and disease-related abnormalities in a multitude of lung and respiratory diseases.
The companies announced that under the extension they would continue working together into the future.